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Background: A number of observational studies have found an association between low vitamin D levels and risk
of sepsis. We conducted a systematic review and meta-analysis to determine the overall estimate of risk.
Methods: This was a systematic review and meta-analysis conducted by online searches (CENTRAL, PubMed/MEDLINE,
and EMBASE) was registered in PROSPERO (CRD42014014767). Primary outcome was incidence, prevalence, relative risk
or odds ratio of having sepsis or bloodstream infection between patients with vitamin D deficiency and controls.
Results: The initial search yielded 647 articles. Twenty-one articles underwent full-length review and data were
extracted from 10 observational studies. Pooled odds ratio of sepsis in participants with vitamin D deficiency was
1.78 (95 % confidence interval [CI] = 1.55 to 2.03, p < 0.01) compared with controls in studies that reported participant
numbers and was 1.45 (95 % CI = 1.26 to 1.66, p < 0.01) in studies that reported an adjusted odds ratio of vitamin D
deficiency for developing sepsis. Statistical between-study heterogeneity was low (I2 = 0 % and 5 %, respectively).
Standardized mean difference of 25-hydroxyvitamin D levels in patients with sepsis and controls was −0.24
(95 % CI = −0.49 to 0.00, p = 0.05) and lower in the sepsis group compared with non-sepsis or control participants. The
statistical between-study heterogeneity (I2) was 0 %.
Conclusion: Vitamin D deficiency were associated with an increased susceptibility of sepsis.
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Vitamin D or cholecalciferol is a fat-soluble vitamin pri-
marily synthesized from 7-dehydroxycholesterol in the
skin by ultraviolet radiation [1]. A previous study
showed that serum concentrations of 25-hydroxyvitamin
D (25(OH)D) were related to geography and season [2].
Lower values were observed in the winter, whereas
higher values were observed in the summer [3]. Addition-
ally, a closer distance to the equator was associated with a
lower magnitude of seasonal variation of 25(OH)D levels
[4, 5]. This variation in vitamin D is resemblance to that in
infection as the incidence and mortality of sepsis is highest
during the winter months and is associated with increased
respiratory illnesses [6]. The association of 25(OH)D* Correspondence: anawin.sanguankeo@bassett.org
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unless otherwise stated.deficiency and infections is likely due to the pleiotropic ef-
fects of 25(OH)D on human immunity, including T-cell
proliferation, immunoglobulin class-switching, and cyto-
kine release [7]. 1,25-dihydroxy vitamin D3 (1,25 (OH)2D)
directly enhances signaling of the innate immune system to
increase the production of antimicrobial peptides (AMP),
such as cathelicidin and LL-37, its activated form [8]. Based
on in vitro studies, LL-37 is active against various patho-
gens including Pseudomonas aeruginosa, Salmonella
typhimurium, Escherichia coli, Listeria monocytogenes,
Staphylococcus epidermidis, Staphylococcus aureus, and
vancomycin-resistant enterococci [9]. The human catheli-
cidin (LL-37) has broad anti-microbial activities against
bacteria, viruses and fungi.
A number of observational studies have found an asso-
ciation between low vitamin D levels and risk of sepsis.
However, the effect of 25(OH)D in different infections is
unclear and sepsis patients can have a heterogeneoushis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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objective of this systematic review and meta-analysis of
observational studies was to comprehensively determine
the strength of association between vitamin D deficiency
and sepsis in hospitalized patients, compared with opti-
mal vitamin D group. The secondary objective was to
determine any difference in 25(OH)D level between sep-
sis patients and controls.
Methods
This systematic review and meta-analysis was conducted
and reported according to established guidelines for meta-
analysis of observational studies [10] and was registered in
PROSPERO (registration number: CRD42014014767).
Criteria for selection of studies for review
Types of studies
All published observational studies including prospective
cohort, retrospective cohort, case-control, and cross-
sectional studies, that evaluated association between
levels of vitamin D (25(OH)D or 1,25-dihydroxyvitamin
D [1,25(OH)2D]) or prevalence of vitamin D deficiency
and the incidence or prevalence of sepsis during
hospitalization were included. Reviews, case reports,
letters, commentaries, abstracts, and unpublished studies
were not included.
Types of participants
Participants of 18 years of age or older who were hospital-
ized and had vitamin D levels (25(OH)D or 1,25(OH)2D)
measured before or during hospitalization were included.
Types of risk factors
We included all studies that defined vitamin D deficiency
as a 25(OH)D level less than 20 ng/mL (50 nmol/L) [11]
or defined an optimal level or vitamin D sufficiency
as a 25(OH)D concentration greater than 30 ng/mL
(75 nmol/L). The latter definition was used to characterize
the optimal group. We reported definition of vitamin D
deficiency and cut-off of 25(OH)D.
Types of outcome measures
Primary outcomes were incidence, prevalence, relative
risk or odds ratio of having sepsis or bloodstream infec-
tion between patients with vitamin D deficiency and
controls. We included studies that defined sepsis as a
systemic inflammatory response syndrome caused by
infection, or having International Classification of Dis-
eases (ICD)-9 codes 038.0–038.9, 995.91, 995.92, or
bloodstream infection. Studies that did not define sepsis
were excluded. A difference in the levels of 25(OH)D
between patients with sepsis and control was the sec-
ondary outcome.Search methods for identification of studies
A.S. and S.U. independently searched published studies
indexed in the Cochrane Central Register of Controlled
Trials (CENTRAL) in The Cochrane Library, PubMed/
MEDLINE, and EMBASE from database inception to
October 2014. References of selected retrieved articles
were also examined. Search terms that were used in-
cluded: vitamin D, 25-hydroxyvitamin D, 25(OH)D,
vitamin D2, vitamin D3, ergocalciferol, cholecalciferol,
calcidiol, calcifediol, calcitriol, sepsis, septicemia, sep-
tic shock. Search terms that were used are detailed in
Additional file 1.
Data collection and analysis
Selection of studies
A.S. and S.U. independently reviewed the titles and ab-
stracts of all citations identified. After all studies were
abstracted, face-to-face data comparisons between inves-
tigators were conducted to ensure completeness and
reliability. The inclusion criteria were independently ap-
plied to all identified studies. Only full-text articles in
English were included in the meta-analysis. Differing de-
cisions were resolved by consensus.
Data extraction and management
Full-text versions of potentially relevant papers identified
in the initial screening were retrieved. Data concerning
study design (cross-sectional, case-control, prospective
cohort, retrospective cohort), participant characteristics
(age, sex, settings), vitamin D levels, participants with
vitamin D deficiency, and outcome measures (definition
of sepsis, number of participants with sepsis, mortality
rates, odds ratio or risk ratio) were independently ex-
tracted. We contacted authors of the primary reports to
request any unpublished data. If the authors did not
reply, we used the available data for our analyses.
Assessment of bias risk
The quality of observational studies was evaluated by two
investigators (A.S. and S.U.) using the Newcastle-Ottawa
quality assessment scale [12]. The NOS is based on three
major components: selection of the study groups (0–4 stars
in cohort study and 0-5 stars in cross-sectional study),
comparability of cases and controls by controlling for rele-
vant factors (0–2 stars), and ascertainment of exposure/
outcome (0–3 stars). A study awarded 7 stars or more is
considered a high-quality study, 4-6 stars is considered a
moderate-quality study, and 0-3 stars is considered a poor-
quality study. We excluded any studies that had poor qual-
ity from the meta-analysis.
Statistical methods
Data analysis was performed using Review Manager 5.3
software from The Cochrane Collaboration. We reported
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between vitamin D deficiency and optimal vitamin D
groups. We also reported standardized mean difference of
25(OH)D levels between sepsis and control groups using a
fixed effects model and inverse variance method. The het-
erogeneity of effect size estimates across these studies was
quantified using the I2 statistic index and Cochran Q test
[13]. Sensitivity analysis was conducted using random ef-
fects model. Publication bias was assessed visually using
funnel plots of standard error vs odds ratio in the meta-
analysis that included five or more studies [14].
Results
Description of included studies
The initial search yielded 647 articles (Fig. 1), of which
626 articles were excluded because they were not obser-
vational studies, participants did not have sepsis out-
come, did not have vitamin D deficiency or vitamin D
levels data, or were in a language other than English. A
total of 21 articles underwent full-length review. Data
were extracted from 10 observational studies [15–24] in-
volving 33,810 participants. All extracted studies wereFig. 1 Results of the information searchincluded in the meta-analysis. The characteristics of the
extracted studies are outlined in Table 1.
Five studies defined vitamin D deficiency as 25(OH)
D ≤15 ng/mL [18, 19, 21, 22, 24] and four studies
defined as 25(OH)D ≤20 ng/mL [16, 17, 20, 23]. Only
one study measured serum 1,25(OH)D2 and compared
between sepsis and control groups [16]. In most stud-
ies, serum were drawn within 7-365 days before admis-
sion. Assays using for serum vitamin D measurement
were ELISA, radioimmunoassay, scintillation proximity
assay, tandem mass spectrometry, and chemilumines-
cence assay.Quality assessment
Quality assessment scores using the Newcastle-Ottawa
Scale tool for observational studies are summarized in
Table 2 and Table 3. Cross-sectional studies had a total
score of 6-7 (selection scale of 2-3, comparability scale
of 0-2, and exposure scale of 3). Cohort studies had a
total score of 7-9 (selection scale of 4, comparability
scale of 0-2, and exposure scale of 3).
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Data are presented as mean (S.D.) or median (interquartile range)
aData in Su et al. are presented in logarithms of the 25-hydroxyvitamin D levels
ACCP, American College of Chest Physicians; BWH, Brigham and Women’s Hospital; MGH, Massachusetts General Hospital; SCCM, Society of Critical Care Medicine; MICU, medical intensive care unit; ICU, intensive care













Table 2 Quality assessment for cross-sectional study
Study
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Table 3 Quality assessment for cohort study











































Braun 2012 * * * * * * * * * 9
Braun 2011 * * * * * * * * * 9
Flynn 2012 * * * * * * * 7
Jovanovich
2014
* * * * * * * * * 9
Moromizato
2013
* * * * * * * * * 9
Quraishi
2013
* * * * * * * * * 9













Fig. 2 Forest plot of comparison of participants with sepsis between vitamin D deficiency (<20 ng/mL) and optimal groups (>30 ng/mL). CI,
confidence interval; SE, standard error; Vit D, vitamin D
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The meta-analysis was performed using the fixed effects
model (Fig. 2, 3, 4). It revealed that the pooled odds ratio
of sepsis in participants with vitamin D deficiency com-
pared with controls was 1.78 (95 % confidence interval
[CI] = 1.55 to 2.03, p < 0.01) in studies that reported the
number of participants with sepsis in vitamin D defi-
ciency and control groups. In studies that reported an
adjusted odds ratio of vitamin D deficiency for develop-
ing sepsis as an outcome, the pooled OR was 1.45 (95 %
CI = 1.26 to 1.66, p < 0.01). The statistical between-study
heterogeneity was low with an I2 of 0 % (Fig. 2) and 5 %
(Fig. 3), respectively. Fig. 4 shows the standardized mean
difference (SMD) of 25(OH)D levels in patients with
sepsis and controls was −0.24 (95 % CI = −0.49 to 0.00,
p = 0.05) and lower in the sepsis group compared with
non-sepsis or control participants. The statistical between-
study heterogeneity (I2) was 0 %.Fig. 3 Forest plot of pooled odds ratio of included studies comparing vitam
confidence interval; Vit D, vitamin DSensitivity analysis
Sensitivity analysis was performed using the random ef-
fects model rather than the fixed effects model. The re-
sult of the direction of point estimate and statistical
difference were not different from the main results.Meta-regression and subgroup analysis
Meta-regression and subgroup analysis were not per-
formed because the between-study heterogeneity was
minimal.Publication bias analysis
Potential publication bias was assessed by funnel plot of
standard error vs odds ratio on the impact of vitamin D
deficiency on sepsis (Fig. 5). It revealed a symmetrical
distribution of included studies and did not show poten-
tial publication bias.in D deficiency (<20 ng/mL) and optimal groups (>30 ng/mL). CI,
Fig. 4 Forest plot of comparison of 25-hydroxyvitamin D (ng/mL) between sepsis and controls. CI, confidence interval; SD, standard deviation
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This systematic review and meta-analysis assessed the
association between vitamin D deficiency, serum 25(OH)
D level and sepsis. We observed that patients with vitamin
D deficiency (25(OH)D < 15-20 ng/mL) measuring before
or during hospitalization have higher odds of sepsis com-
pared to individuals without vitamin D deficiency. We did
not find a significant difference of 25(OH)D level between
patients who had and did not have sepsis.
Low serum 25(OH)D levels are a common problem in
the United States. Based on data from the US National
Health and Nutrition Examination Survey (NHANES) in
2001–2006, two-thirds of the population had sufficient
vitamin D. About one-quarter were at risk of vitamin D
inadequacy, and 8 % were at risk of vitamin D deficiency
[25]. The results of the current study reveal a statistically
significant increased odds of vitamin D deficiency among
septic patients. This meta-analysis finding is in agreement
with other critical care studies’ findings. They revealedFig. 5 Funnel plots showing publication bias in the studies reporting num
groups. Circles represent observed published studiesthat low serum concentrations of 25(OH)D was associated
with adverse clinical outcomes, including increased mor-
tality rate, increased length of hospital stay, and acute kid-
ney injury in a critical care setting not limited to severe
infection and sepsis [26–28]. There were also evidences
that deficiency in 25(OH)D and 1,25(OH)2D were signifi-
cant predictors of 30-day mortality in septic patients
[29, 30]. A pathophysiology that underlies cause of sepsis in
vitamin D deficiency could be due to innate immune dys-
function [31]. Moreover, a reduction in 1,25(OH)2D at the
tissue level may lower its pleiotropic effects on immune
regulation, mucosal and endothelial function [32, 33].
Many randomized clinical studies did not find benefits
on severe infections or sepsis after vitamin D normalization
in vitamin D deficient patients [34–37]. The reason could
be due to underpowered numbers, low dosages or short
duration of supplementation. In most recent clinical trial of
475 patients with vitamin D deficiency [38], administration
of high-dose vitamin D3 compared with placebo did notber of participants with sepsis in vitamin D deficiency and optimal
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month mortality. However, hospital-mortality and mortality
rates in this study were significantly lower in the severe
vitamin D deficiency subgroup (25-hydroxyvitamin D level
less than 12 ng/mL). Further clinical trial exploring effects
of vitamin D supplementation on severe infection or sepsis
in severe vitamin D deficiency patients is needed.
The results of this study should be cautiously inter-
preted because of several limitations in this meta-analysis
of observational studies. A major limitation is the small
number of studies that met our inclusion criteria. Add-
itionally, analyzed results were from observational studies,
which could contain potential confounders from factors in
selected populations, such as age, gender, comorbidities,
and prolonged hospitalization that might affect the risk of
infection and having sepsis. Studies that measured serum
25(OH)D on admission or after hospitalization may not
represent pre-illness vitamin D level. The vitamin D level
could be underestimate from severe illness, or overesti-
mate from vitamin D supplementation. We can assume
that vitamin D level measuring before admission (at least
7 days) is not effected by critical illness. It is also a limita-
tion to prevent sepsis by keeping optimal or normal vita-
min D level in general population. It may also be difficult
to normalize vitamin D in critically-ill patients.Conclusions
In conclusion, we confirm previous study findings that
vitamin D deficiency by having serum 25(OH)D less
than 15-20 ng/mL is associated with higher chance of
sepsis. Larger prospective observational studies that
measure vitamin D level before critical illness are required
to determine the causal relationship of sepsis. Further ran-
domized controlled trials are needed to determine the role
of vitamin D normalization before or during critical ill-
ness, and to investigate whether it can prevent infection
or improve clinical outcomes in infected organ systems.Additional file
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